Filing Flows › Prestige Consumer Healthcare (PBH) › Gastrointestinal revenue
Prestige Consumer Healthcare (PBH) Gastrointestinal revenue by quarter
Prestige Consumer Healthcare's Gastrointestinal revenue was $63.1M in Q2 FY27 (second quarter fiscal 2027), +1% from Q1 FY27. Over the last 7 quarters it ranged from $57.8M (Q1 FY26) to $69.5M (Q3 FY26).
| Quarter | Gastrointestinal revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 FY27 | $63.1M | +1% | -2% |
| Q1 FY27 | $62.2M | -9% | +8% |
| Q4 FY26 | $68.3M | -2% | -0.8% |
| Q3 FY26 | $69.5M | +8% | — |
| Q2 FY26 | $64.2M | +11% | — |
| Q1 FY26 | $57.8M | -16% | — |
| Q4 FY25 | $68.9M | — | — |
Q2 FY27 at a glance
Prestige Consumer Healthcare, Q2 FY27: revenue $336M (+23% year over year), operating margin 24.0%, net earnings $25.3M, operating cash flow $37.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Prestige Consumer Healthcare's Gastrointestinal revenue?
Prestige Consumer Healthcare's Gastrointestinal revenue was $63.1M in Q2 FY27 (second quarter fiscal 2027), +1% from Q1 FY27.
How has Prestige Consumer Healthcare's Gastrointestinal revenue changed?
Over the last 7 quarters it ranged from $57.8M (Q1 FY26) to $69.5M (Q3 FY26).
Q2 FY27 results → · How Prestige Consumer Healthcare makes money →